127 related articles for article (PubMed ID: 4876253)
1. [Tissue culture and cancer chemotherapy].
Tanneberger S
Arch Geschwulstforsch; 1968; 31(4):387-400. PubMed ID: 4876253
[No Abstract] [Full Text] [Related]
2. [Evolution of chemotherapy of cancer. Conceptuals models].
Lopez M
Clin Ter; 2000; 151(1):49-55. PubMed ID: 10822882
[No Abstract] [Full Text] [Related]
3. [In vitro chemotherapeutic screening of human cancer tissue prior to treatment].
Adler A; Keinan Z; Maor M; Stein JA
Harefuah; 1972 Jan; 82(2):49-55. PubMed ID: 4563958
[No Abstract] [Full Text] [Related]
4. Propagation of cancer: targets for future chemotherapy.
Leighton J
Cancer Res; 1969 Dec; 29(12):2457-65. PubMed ID: 4905241
[No Abstract] [Full Text] [Related]
5. [Selective chemotherapy of human tumors. Methods and clinical experiences].
Wust G
Med Welt; 1967 Dec; 50():3035-42. PubMed ID: 5610826
[No Abstract] [Full Text] [Related]
6. [Analysis of the cycle phases of normal tissue and cancerous tissue cells and its importance in cancer chemotherapy].
Hrushovetz SB
Laval Med; 1968 Oct; 39(8):673-83. PubMed ID: 5748233
[No Abstract] [Full Text] [Related]
7. [Individualized drug therapy of cancer based on an in vitro test].
Tveit KM
Tidsskr Nor Laegeforen; 1983 Jan; 103(2):113-6. PubMed ID: 6845299
[No Abstract] [Full Text] [Related]
8. Cell biological systems for prediction of individual human tumor drug sensitivity.
Tanneberger S; Nissen E
Prog Clin Biol Res; 1983; 132E():129-43. PubMed ID: 6647463
[No Abstract] [Full Text] [Related]
9. Combination of sulfated oligosaccharides and chemotherapy: a novel therapeutic strategy for cancer.
Wu XZ
Med Hypotheses; 2006; 67(4):991-2. PubMed ID: 16713127
[No Abstract] [Full Text] [Related]
10. Mathematical modeling of cancer progression and response to chemotherapy.
Sanga S; Sinek JP; Frieboes HB; Ferrari M; Fruehauf JP; Cristini V
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1361-76. PubMed ID: 17069522
[TBL] [Abstract][Full Text] [Related]
11. Therapy burden, drug resistance, and optimal treatment regimen for cancer chemotherapy.
Boldrini JL; Costa MI
IMA J Math Appl Med Biol; 2000 Mar; 17(1):33-51. PubMed ID: 10757031
[TBL] [Abstract][Full Text] [Related]
12. [Pretherapeutic detection of tumour resistance to cytostatic agents].
Volm M; Mattern J
Wien Klin Wochenschr; 1982 Nov; 94(22):599-604. PubMed ID: 7164463
[TBL] [Abstract][Full Text] [Related]
13. Establishment of in-vitro models of chemotherapy resistance.
Watson MB; Lind MJ; Cawkwell L
Anticancer Drugs; 2007 Aug; 18(7):749-54. PubMed ID: 17581296
[TBL] [Abstract][Full Text] [Related]
14. [Dynamic circadian system patients under chimiotherapy].
Beau J; Iurisci I; Beau T; Lévi F
Pathol Biol (Paris); 2007; 55(3-4):171-5. PubMed ID: 17412521
[TBL] [Abstract][Full Text] [Related]
15. Preferential attack on cancer following major cancer surgery.
Knock FE; Galt RM; Oester YT; Sylvester R; Renaud OV
Int Surg; 1971 Feb; 55(2):104-9. PubMed ID: 5545535
[No Abstract] [Full Text] [Related]
16. [Cancer chemotherapy and hormone therapy].
Bourgeois H; Farnault G
Soins; 1996 Dec; (611):5-10. PubMed ID: 9070800
[No Abstract] [Full Text] [Related]
17. [The use of cell cultures for the determination of the sensitivity of human tumors to cytostatic agents].
Tanneberger S; Bacigalupo G
Dtsch Gesundheitsw; 1967 Jan; 22(1):11-5. PubMed ID: 5584377
[No Abstract] [Full Text] [Related]
18. Cancer chemotherapy.
Med Lett Drugs Ther; 1983 Jan; 25(626):1-8. PubMed ID: 6848903
[No Abstract] [Full Text] [Related]
19. Screening data from the Cancer Chemotherapy National Service Center screening laboratories. XXXV.
Schepartz SA; Abbott BJ; Leiter J
Cancer Res; 1966 Aug; 26(8 Pt 2):950-1113. PubMed ID: 5950748
[No Abstract] [Full Text] [Related]
20. Screening data from the Cancer Chemotherapy National Service Center screening laboratories. 43.
Schepartz SA; Abbott BJ; Leiter J
Cancer Res; 1967 Aug; 27(8 Pt 2):737-920. PubMed ID: 6050920
[No Abstract] [Full Text] [Related]
[Next] [New Search]
